In contrast to A2780 and 2780CP ovarian cancer cells, the effects of cisplatin in cisplatin-sensitive and cisplatin-resistant testicular cancer cell lines (Tera and Tera-CP, respectively) were associated with the activation of p53 [138]. The gene discussed is TP53; the disease is ovarian carcinoma.